Key result
Doxorubicin induces sex-divergent cardiac proteomic remodeling across ~430 proteins regulating mitochondrial and calcium handling.
Why the study?
Anthracycline-induced cardiotoxicity has substantial inter-individual variability and documented sex differences, but the underlying molecular basis remains incompletely understood.
Does doxorubicin induce sex-specific early cardiac proteomic remodeling and functional decline in a rat model?
Does doxorubicin induce sex-specific early cardiac proteomic remodeling and functional decline in a rat model?
p-value: p=<0.05
Doxorubicin induces sex-specific early cardiac proteomic remodeling, with females showing upregulation of protective mitochondrial proteins that may explain their delayed onset of systolic dysfunction compared to males.
Sex-specific proteomic remodeling after doxorubicin in rats may underlie clinical sex differences in cardiotoxicity; hypothesis-generating and requires human validation.
Anthracycline-induced cardiotoxicity remains a major limitation in cancer therapy, with substantial inter-individual variability in susceptibility, including documented sex differences. However, the molecular basis underlying these disparities remains incompletely understood. In this study, we employed large-scale data-independent acquisition proteomics in a long-latency rat model of doxorubicin-induced cardiomyopathy to characterize early cardiac proteomic remodeling. Longitudinal echocardiography demonstrated a significantly greater decline in fractional shortening in males compared to females. Early proteomic profiling identified 5185 proteins and revealed widespread remodeling across metabolic, mitochondrial, cytoskeletal, and stress-response pathways. While doxorubicin induced broad proteomic changes in both sexes, two-way limma-based sex-stratified analyses identified 431 proteins exhibiting significant sex-by-treatment interactions. Our results suggested that doxorubicin was associated with alterations in oxidative phosphorylation, fatty acid metabolism, and calcium handling pathways. A female-specific upregulation of mitochondrial proteins, including Sco1, Cox17, and Atp2a2, which may be associated with preserved energetics and Ca 2+ handling, was detected. In contrast, male hearts demonstrated reduced Micu1 and RyR2 together with increased levels of Ppp1ca, findings that may indicate alterations in mitochondrial function and, excitation–contraction coupling. We also observed lower levels of calcineurin (Ppp3cb) in females. Baseline proteomic differences between sexes further implied distinct regulatory states that may shape the cardiac response to doxorubicin.Together, these findings suggest early proteomic remodeling upon doxorubicin treatment and represent candidate molecular targets that warrant functional validation in future studies. This work offers hypothesis-generating mechanistic insights into sex-specific responses to anthracycline-induced cardiomyopathy and underscores the importance of incorporating sex as a biological variable in cardio-oncology research.
No takes yet. Share an insight, caveat, or question.
Sedighi et al. (2026) studied Doxorubicin-induced cardiomyopathy (n=12). Doxorubicin vs. Saline was evaluated on Proteins exhibiting significant sex-by-treatment interactions (p=<0.05). Doxorubicin induced broad proteomic changes, with 431 proteins exhibiting significant sex-by-treatment interactions, including female-specific upregulation of mitochondrial proteins and male-specific reduction in calcium handling proteins.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: